Advisors Asset Management, Inc. Guardant Health, Inc. Transaction History

Advisors Asset Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$109.77 - $165.68 $52,909 - $79,857	-482 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$127.04 - $179.1 $20,326 - $28,656	160 Added 49.69%	482 $74,000
Q4 2020 Feb 12, 2021	SELL	$99.96 - $135.93 $10,295 - $14,000	-103 Reduced 24.24%	322 $41,000
Q2 2020 Aug 12, 2020	SELL	$60.49 - $97.5 $60 - $97	-1 Reduced 0.23%	425 $34,000
Q1 2020 May 15, 2020	BUY	$59.04 - $88.81 $2,125 - $3,197	36 Added 9.23%	426 $30,000
Q4 2019 Feb 14, 2020	SELL	$59.49 - $82.78 $136,529 - $189,980	-2,295 Reduced 85.47%	390 $30,000
Q3 2019 Nov 14, 2019	BUY	$62.59 - $110.3 $168,054 - $296,155	2,685 New	2,685 $171,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.23B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisors Asset Management, Inc. with notifications on news.